ReviewOncology and therapy2024

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers.

Matthew J Monberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.